Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells

BACKGROUND: Tamoxifen and fulvestrant, both approved for endocrine therapy, have remarkably increased the prognosis of hormone receptor-positive breast cancer patients. However, acquired resistance to endocrine therapy greatly reduces its clinical efficacy. Accumulating evidence suggests a pivotal r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Liang, Shen, Kunwei, Yin, Ni, Jiang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723334/
https://www.ncbi.nlm.nih.gov/pubmed/33324567
http://dx.doi.org/10.3389/fonc.2020.600487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723334/
https://www.ncbi.nlm.nih.gov/pubmed/33324567
http://dx.doi.org/10.3389/fonc.2020.600487

Ejemplares similares